BACKGROUND: To establish maternal thyroid-stimulating hormone (TSH) reference ranges for first trimester screening from 11 + 0 to 13 + 6 weeks of gestation. METHODS: A total of 10 592 singleton and 201 twin consecutive Caucasian pregnant women who underwent simultaneously prenatal first trimester Down's syndrome screening and thyroid function screening from January 2010 to November 2017 were included in the study. Women with positive antithyroid peroxidase antibody (TPOAb) and positive personal history of thyroid disease were previously excluded. TSH was measured by immunochemiluminescent assay on ci 16200 Abbott Architect analyzer. Nonparametric percentile method (also known as CLSI C28.A3) was used for the determination of reference ranges. RESULTS: We established reference ranges of TSH for the period of gestation from 11 + 0 to 13 + 6 weeks of pregnancy as 0.16-3.43 mU/L for singleton Caucasian pregnancies and 0.02-2.95 mU/L for twin Caucasian pregnancies. The median (IQR) of TSH for singleton pregnancies was higher than that for twin pregnancies (1.25 mU/L (0.83-1.81) vs 0.84 (0.37-1.47), respectively; P < .0001). CONCLUSIONS: Each first trimester screening center should be aware of which type of immunoassay their laboratory uses. TSH reference ranges in women during the first trimester of pregnancy are lower than those for general population. Twin pregnancies have lower TSH than singleton pregnancies.

Department of Clinical Biochemistry and Pharmacology Tomas Bata Hospital in Zlín Zlín Czech Republic

Department of Obstetrics and Gynecology Tomas Bata Hospital in Zlín Zlín Czech Republic

FETMED Olomouc Ostrava Czech Republic

Internal Medicine Clinic Tomas Bata Hospital in Zlín Zlín Czech Republic

Medical Faculty University of Ostrava in Ostrava Ostrava Czech Republic

See more in PubMed

Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315‐389. PubMed

Springer D, Jiskra J, Limanova Z, Zima T, Potlukova E. Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci. 2017;54:102‐116. PubMed

Šálek T, Franeková J, Jabor A, et al. Postanalytical phase and interpretation of laboratory tests. Klin Biochem Metab. 2016;24:82‐87.

Jones GRD. The role of EQA in harmonization in laboratory medicine – a global effort. Biochem Med (Zagreb). 2017;27:23‐29. PubMed PMC

Zamrazil V, Bilek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid. 2004;14:49‐56. PubMed

Guidi GC, Salvagno GL. Reference intervals as a tool for total quality management. Biochem Med (Zagreb). 2010;20:165‐172.

Springer D, Bartos V, Zima T. Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems. Scand J Clin Lab Invest. 2014;74:95‐101. PubMed

Gilbert RM, Hadlow NC, Walsh JP, et al. Assessment of thyroid function during pregnancy: first‐trimester (weeks 9‐13) reference intervals derived from Western Australian women. Med J Aust. 2008;189:250‐253. PubMed

Rosario PW, Carvalho M, Calsolari MR. TSH reference values in the first trimester of gestation and correlation between maternal TSH and obstetric and neonatal outcomes: a prospective Brazilian study. Arch Endocrinol Metab. 2016;60:314‐318. PubMed PMC

Ashoor G, Muto O, Poon LCY, Muhaisen M, Nicolaides KH. Maternal thyroid function at gestational weeks 11–13 in twin pregnancies. Thyroid. 2013;23:1165‐1171. PubMed

Dhaifalah I, Salek T, Langova D, Cuckle H. Incorporating thyroid markers in Down's syndrome screening protocols. Prenat Diagn. 2017;37:510‐514. PubMed